Virtual reality exposure therapy and fibromyalgia

• Register: PACTR
• Last refreshed on: 29 April 2013
• Main ID: PACTR201011000264179
• Date of registration: 17/11/2010
• Primary sponsor: Linzette Morris
• Public title: Virtual reality exposure therapy and fibromyalgia
• Scientific title: Virtual reality exposure therapy therapy as treatment for pain catastrophizing in fibromylagia patients: Proof-of-concept
• Date of first enrolment: 2011-02-07
• Target sample size: 20
• Recruitment status: Not yet recruiting
• URL: HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201011000264179
• Study type: interventional
• Study design: Parallel: different groups receive different interventions at same time during study,; Randomised,; Statistician will build a computer-generated random numbers table will be used to allocate subjects to groups. ,; Allocation will be concealed by placing group identification in sealed opaque envelopes,

Countries of recruitment

South Africa

Contacts

• Name: Linzette Morris
• Affiliation: Researcher/Stellenbosch University

• Name: Linzette Morris
• Affiliation: Researcher/Stellenbosch University

Key inclusion & exclusion criteria

Inclusion criteria: Adult male and female subjects
Between ages of 18 and 65 years old
clinically diagnosed with FMS according to the American College Rheumatology (ACR) criteria [26] by a qualified rheumatologist subjectively report high PCS (more than 24 points) and TSK (more than 37 points) scores
able to speak, read English, Afrikaans and Xhosa
Exclusion criteria: diagnosed with other conditions not related to FMS i.e. cancer;
severe physical disabilities;
suffer from other chronic conditions i.e. systemic lupus erythmatosus, rheumatoid arthritis, etc;
previously been hospitalized for a major psychiatric disorder;
uncontrolled endocrine or allergic disorder; using medication other than the prescribed pharmacologic agents for FMS symptoms;
using any narcotics long-term;
currently or who have previously abused any illicit substances or alcohol;
diagnosed with epilepsy, or other conditions contraindicated in the use of visual exposures to stimuli;
contraindications which prohibit the use of fMRI, i.e. cardiac pacemakers, metal implants, claustrophobia, pregnancy and cochlear implants;
unable to discontinue intake of anti-depressants 4 weeks prior to commencement of study

Age minimum: 18 Year
Age maximum: 65 Year
Gender: Both

Health Condition(s) or Problem(s) studied

Fibromyalgia

Primary Outcome(s)

pain catastrophizing

Secondary Outcome(s)

Kinesiophobia

Secondary ID(s)

N10/05/184

Source(s) of Monetary Support

National Research Fund

Harry Crossley Foundation

Stellenbosch University Postgraduate merit award